Obstetrics & Gynecology · Thousand Oaks, CA
NPI
1861660144
Since 2008
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
415 E. Rolling Oaks Dr, #260
Thousand Oaks, CA, 91361
Phone (805) 371-4700
Groups this clinician bills Medicare through
Medicare paid, 2024
$276K
5,335 services
Medicare patients, 2024
1,183
Average age 74
Drug cost, 2024
$261K
2,533 prescriptions
Company payments, 2025
$519
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karie T McMurray was code 96127 (behavioral health services), 1,109 times for 1,107 patients. In total Karie T McMurray billed 5,335 services in 32 codes, and Medicare paid $276K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 96127 Behavioral Health Services | Office | 1,109 | 1,107 | $3.90 | $4,326 |
| 82270 Immunoassay | Office | 1,063 | 1,063 | $4.29 | $4,560 |
| 99215 Office E&M - Established | Office | 936 | 906 | $136.29 | $128K |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 699 | 699 | $42.46 | $30K |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 591 | 591 | $49.61 | $29K |
| 99213 Office E&M - Established | Office | 250 | 163 | $72.48 | $18K |
| 99205 Office E&M - New | Office | 195 | 195 | $170.55 | $33K |
| 99214 Office E&M - Established | Office | 178 | 149 | $96.97 | $17K |
| 81002 Clinical Chemistry | Office | 77 | 65 | $3.41 | $263 |
| 99212 Office E&M - Established | Office | 29 | 21 | $47.65 | $1,382 |
| 51798 Ultrasound - Nonspecific | Office | 25 | 20 | $10.47 | $262 |
| 58100 Other Organ Systems | Office | 24 | 23 | $82.49 | $1,980 |
| 99204 Office E&M - New | Office | 21 | 21 | $133.41 | $2,802 |
By year: 2022 $205K for 2,975 services; 2023 $227K for 3,733 services; 2024 $276K for 5,335 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82270 Immunoassay | 1,063 | 1,063 | $4.29 | $4,560 |
| 81002 Clinical Chemistry | 77 | 65 | $3.41 | $263 |
Medicare prescription drug claims, 2024
In 2024, the drug Karie T McMurray prescribed most often to Medicare patients was Progesterone (Progesterone, Micronized), with 421 prescriptions and refills. In total Karie T McMurray wrote 2,533 Medicare prescriptions that cost $261K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Progesterone Progesterone, Micronized | 421 | 1,184 | 138 | $15K |
| Estradiol (Twice Weekly) Estradiol | 222 | 552 | 82 | $26K |
| Estradiol Generic | 202 | 514 | 100 | $18K |
| Levothyroxine Sodium Generic | 146 | 408 | 38 | $1,445 |
| Atorvastatin Calcium Generic | 143 | 421 | 44 | $1,416 |
| Alprazolam Generic | 132 | 138 | 36 | $400 |
| Dotti Estradiol | 85 | 208 | 35 | $11K |
| Valacyclovir Valacyclovir Hcl | 82 | 166 | 47 | $4,010 |
| Myrbetriq Mirabegron | 79 | 163 | 19 | $70K |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 77 | 80 | 54 | $1,540 |
| Synthroid Levothyroxine Sodium | 76 | 226 | 23 | $8,482 |
| Spironolactone Generic | 51 | 151 | 17 | $462 |
| Fluconazole Generic | 48 | 57 | 34 | $211 |
| Escitalopram Oxalate Generic | 41 | 121 | 12 | $387 |
| Alendronate Sodium Generic | 36 | 101 | 11 | $126 |
Brand drugs: 506 claims; generic drugs: 2,005 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karie T McMurray $519 ($519 in general payments such as food, travel and fees) from 8 companies. The largest payer was Abbvie Inc. with $193.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.